Targeting Lipid Metabolism and Free Fatty Acid (FFA) Oxidation to Treat Diseases Mediated by Resident Memory T Cells (TRM)
申请人:The Brigham and Women's Hospital, Inc.
公开号:US20200375965A1
公开(公告)日:2020-12-03
Methods for treating, or reducing risk of development or progression of, a tissue-resident memory T cells (TRM)-mediated disease, comprising administering a therapeutically effective amount of one or more inhibitors of exogenous lipid and free fatty acid uptake or of mitochondrial beta oxidation of internalized exogenous FFA (e.g., inhibitors of CD36 and/or FABP antagonists, e.g., inhibitors of FABP4 and/or FABP5, and/or CPT1) to a subject in need thereof.